Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.2/5

Concord Biotech Ltd (CONCORDB IN)

26
Analysis
Health Care • India
Concord Biotech Ltd. provides pharmaceutical products. The Company offers active pharmaceutical ingredients, finished dosages formulations, and other related products, as well as provides contract research and manufacturing services. Concord Biotech serves customers in India.
more
bullish•Concord Biotech Ltd
•02 Aug 2023 10:16

Concord Biotech (Pre-IPO): Niche Offering Amid Lean Competition to Drive Stable Growth

The IPO consists of offer for sale of 21M shares by Helix Investment Holdings at a price band of INR705–741/share. Through this IPO, Concord seeks...

Logo
392 Views
Share
bullish•Concord Biotech Ltd
•02 Aug 2023 06:49

Concord Biotech IPO - RHP Updates - Continued Growing Although Concentration Risk Remains Elevated

Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. Concord is an India-based biopharma firm, which develops and...

Logo
485 Views
Share
•24 Feb 2023 03:04

IdeaForge Pre-IPO Tearsheet

IdeaForge Technology Limited (1475641D IN) is looking to raise around US$100m in its upcoming India IPO. Some of its notable pre-IPO investors...

Logo
582 Views
Share
bullish•Adani Enterprises
•05 Feb 2023 00:00

ECM Weekly (5th Feb 2023) - Adani, Pertamina, Hesai, Ruipeng Pet, Concord, Oasis, Flight Centre

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
570 Views
Share
bullish•Concord Biotech Ltd
•30 Jan 2023 03:03

Concord Biotech Pre-IPO - Sales Have Been Growing but Watch Out for Its High Concentration Risk

Concord Biotech Ltd (658823Z IN) is looking to raise around US$250m in its upcoming India IPO. Concord is an India-based biopharma firm, which...

Logo
490 Views
Share
x